Last deal

$2M

Amount

Grant

Stage

15.08.2024

Date

4

all rounds

$7.6M

Total amount

General

About Company
Alpenglow Biosciences uses AI-enabled 3D imaging to accelerate drug development.

Industry

Sector :

Subsector :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Seattle-based Alpenglow Biosciences is an early-stage life sciences company that partners with pharmaceutical companies to improve drug development and clinical diagnostics. Their platform solution digitizes entire tissues while keeping samples intact, providing new spatial biology insights with greater accuracy. Alpenglow's patented technology helps pharmaceutical companies gain new insights into biodistribution, mechanism of action, and potential candidate ranking. They have collaborations with five of the top 10 pharma companies, helping to accelerate development timelines and improve therapeutic success. Alpenglow is currently hiring for various roles in business development, wet lab, hardware, and software.
Contacts